Gefitinib vs Sitagliptin

Gefitinib vs Sitagliptin: Overview

This comparison examines the pharmacological differences between Gefitinib and Sitagliptin.

Mechanism of Action

Gefitinib: Selective reversible inhibitor of EGFR tyrosine kinase.

Sitagliptin: DPP-4 inhibitor increasing incretin levels.

Pharmacokinetics

Half-life: Gefitinib — 48 hours; Sitagliptin — 12.4 hours.

Chemical Properties

Molecular Formula: Gefitinib — C22H24ClFN4O3; Sitagliptin — C16H15F6N5O.

Molecular Weight: Gefitinib — 446.9000 g/mol; Sitagliptin — 407.3140 g/mol.

Type: Gefitinib — Small molecule; Sitagliptin — Small molecule.